Dr Paxton Loke
Dr Paxton Loke
Details
Role
Research Clinician
Research area
Infection, Immunity and Global Health
Group
Allergy Immunology
Dr Paxton Loke is a Research Clinician in the Allergy Immunology group at the Murdoch Children's Research Institute, Consultant Paediatric Allergist Immunologist at Monash Children’s Hospital and MACCS Medical Group and Honorary Fellow at the University of Melbourne. His main research interest is in food oral immunotherapy where he is the Principal Investigator on the multi-centre Probiotic and Peanut Oral Immunotherapy clinical trial and its follow-on study that aims to induce long lasting clinical remission to peanut in children, and an Investigator on probiotic egg and cow’s milk OIT clinical trials.
Dr Paxton Loke is a Research Clinician in the Allergy Immunology group at the Murdoch Children's Research Institute, Consultant Paediatric Allergist Immunologist at Monash Children’s Hospital and MACCS Medical Group and Honorary Fellow at the...
Dr Paxton Loke is a Research Clinician in the Allergy Immunology group at the Murdoch Children's Research Institute, Consultant Paediatric Allergist Immunologist at Monash Children’s Hospital and MACCS Medical Group and Honorary Fellow at the University of Melbourne. His main research interest is in food oral immunotherapy where he is the Principal Investigator on the multi-centre Probiotic and Peanut Oral Immunotherapy clinical trial and its follow-on study that aims to induce long lasting clinical remission to peanut in children, and an Investigator on probiotic egg and cow’s milk OIT clinical trials.
Top Publications
- Rosser, SA, Lloyd, M, Hu, A, Loke, P, Tang, MLK. Associations between gender and health‐related quality of life in people with IgE‐mediated food allergy and their caregivers: A systematic review. Clinical & Experimental Allergy 2024 view publication
- Parker, K, Wijesuriya, R, Dang, T, Soriano, V, Lowe, A, Dharmage, S, Loke, P, Koplin, J, Perrett, K, Peters, R. Longitudinal peanut and Ara h 2 specific-IgE, -IgG4 and -IgG4/-IgE ratios are associated with the natural resolution of peanut allergy in childhood. Journal of Allergy and Clinical Immunology 153(2) : ab33 2024 view publication
- Loke, P, Hsiao, K-C, Lozinsky, A, Ashley, S, Lloyd, M, Pitkin, S, Axelrad, C, Jayawardana, K, Tey, D, Su, E-L, et al. Probiotic and Peanut OIT leads to long-lasting sustained unresponsiveness and quality-of-life improvement in peanut-allergic children. 2024 view publication
- William, VM, Koplin, J, Allen, K, Robinson, M, smart, J, Loke, P, Peters, R, Dang, T, Lee, K, Dalziel, K, et al. TreEAT Trial: protocol for a randomised controlled trial investigating the efficacy and safety of early introduction of tree nuts for the prevention of tree nut allergy in infants with peanut allergy.. 2024 view publication
- Huang, L, Dalziel, K, Lloyd, M, Loke, P, Lozinsky, AC, Tang, M. Cost-effectiveness analysis of probiotic peanut oral immunotherapy (PPOIT) versus placebo in Australian children with peanut allergy alongside a randomised trial. BMJ Open 13(12) : e075521 2023 view publication
Page 1 of 12
Share //
